• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
Generic Name:  sodium chlorite
Trade Name:  n/a
Date Designated:  08/22/2011
Orphan Designation:  For slowing the progression of amyotrophic lateral sclerosis.
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Neuraltus Pharmaceuticals, Inc.
2483 E. Bayshore Road
Suite 212
Palo Alto, California 94303

The sponsor address listed is the last reported by the sponsor to OOPD.